세계의 외래 수면다원검사(PSG) 시스템 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2025-2033년)

Global Ambulatory Polysomnography (PSG) System Market size is anticipated to grow from USD 433.95 Million in 2024 to USD 777.24 Million by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 6.69% during the forecast period of 2026 to 2033.

The ambulatory polysomnography (PSG) system market is entering a dynamic phase of growth, driven by the increasing prevalence of sleep disorders and the rising demand for home-based diagnostic solutions. As healthcare systems evolve towards more patient-centric models, the convenience and accessibility of ambulatory PSG systems are becoming increasingly appealing. These systems not only facilitate the diagnosis of conditions such as sleep apnea but also empower patients to undergo testing in the comfort of their homes, thereby enhancing compliance and reducing the burden on healthcare facilities.

Technological advancements are at the forefront of this market's evolution, with innovations in wearable devices and mobile health applications enhancing the accuracy and efficiency of sleep studies. The integration of artificial intelligence and machine learning algorithms into PSG systems is further revolutionizing data analysis, enabling clinicians to derive actionable insights from complex datasets. This technological synergy is expected to streamline the diagnostic process, leading to timely interventions and improved patient outcomes.

Moreover, the growing awareness of the importance of sleep health is catalyzing market expansion. Public health campaigns and educational initiatives are fostering a greater understanding of sleep disorders, prompting individuals to seek diagnostic services proactively. As healthcare providers increasingly recognize the significance of sleep in overall health, the demand for ambulatory PSG systems is anticipated to surge. In this evolving landscape, stakeholders are well-positioned to capitalize on the opportunities presented by the ambulatory PSG system market, paving the way for innovative solutions that enhance sleep health management.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Product

• Up to 12 Channel PSG Systems
• Up to 24 Channel PSG Systems
• Up to 32 Channel PSG Systems
• Above 32 Channel PSG Systems

By Application

• Obstructive Sleep
• Apnea Narcolepsy
• Chronic Insomnia
• Others

By End-user

• Hospitals
• Sleep Laboratories
• Home Care Settings
• COMPANIES PROFILED
• Compumedics Limited
• Nihon Kohden Corporation
• Koninklijke Philips N.V.
• SOMNOmedics GmbH
• Cadwell Industries Inc.
• Natus Medical Incorporated
• Lowenstein Medical Technology GmbH + Co. KG.
• Nox Medical
• Neurosoft
• The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEM INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porters Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product
  • 3.7.2 Market Attractiveness Analysis By Application
  • 3.7.3 Market Attractiveness Analysis By End-user
  • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEM MARKET ANALYSIS BY PRODUCT

• 5.1. Overview By Product
• 5.2. Historical and Forecast Data Analysis By Product
• 5.3. Up to 12 Channel PSG Systems Historic and Forecast Sales By Regions
• 5.4. Up to 24 Channel PSG Systems Historic and Forecast Sales By Regions
• 5.5. Up to 32 Channel PSG Systems Historic and Forecast Sales By Regions
• 5.6. Above 32 Channel PSG Systems Historic and Forecast Sales By Regions

6. GLOBAL AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEM MARKET ANALYSIS BY APPLICATION

• 6.1. Overview By Application
• 6.2. Historical and Forecast Data Analysis By Application
• 6.3. Obstructive Sleep Historic and Forecast Sales By Regions
• 6.4. Apnea Narcolepsy Historic and Forecast Sales By Regions
• 6.5. Chronic Insomnia Historic and Forecast Sales By Regions
• 6.6. Others Historic and Forecast Sales By Regions

7. GLOBAL AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEM MARKET ANALYSIS BY END-USER

• 7.1. Overview By End-user
• 7.2. Historical and Forecast Data Analysis By End-user
• 7.3. Hospitals Historic and Forecast Sales By Regions
• 7.4. Sleep Laboratories Historic and Forecast Sales By Regions
• 7.5. Home Care Settings Historic and Forecast Sales By Regions

8. GLOBAL AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEM MARKET ANALYSIS BY GEOGRAPHY

• 8.1. Regional Outlook
• 8.2. Introduction
• 8.3. North America Sales Analysis
  • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.3.2 North America By Segment Sales Analysis
  • 8.3.3 North America By Country Sales Analysis
  • 8.3.4 United States Sales Analysis
  • 8.3.5 Canada Sales Analysis
  • 8.3.6 Mexico Sales Analysis
• 8.4. Europe Sales Analysis
  • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.4.2 Europe By Segment Sales Analysis
  • 8.4.3 Europe By Country Sales Analysis
  • 8.4.4 United Kingdom Sales Analysis
  • 8.4.5 France Sales Analysis
  • 8.4.6 Germany Sales Analysis
  • 8.4.7 Italy Sales Analysis
  • 8.4.8 Russia Sales Analysis
  • 8.4.9 Rest Of Europe Sales Analysis
• 8.5. Asia Pacific Sales Analysis
  • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.5.2 Asia Pacific By Segment Sales Analysis
  • 8.5.3 Asia Pacific By Country Sales Analysis
  • 8.5.4 China Sales Analysis
  • 8.5.5 India Sales Analysis
  • 8.5.6 Japan Sales Analysis
  • 8.5.7 South Korea Sales Analysis
  • 8.5.8 Australia Sales Analysis
  • 8.5.9 South East Asia Sales Analysis
  • 8.5.10 Rest Of Asia Pacific Sales Analysis
• 8.6. Latin America Sales Analysis
  • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.6.2 Latin America By Segment Sales Analysis
  • 8.6.3 Latin America By Country Sales Analysis
  • 8.6.4 Brazil Sales Analysis
  • 8.6.5 Argentina Sales Analysis
  • 8.6.6 Peru Sales Analysis
  • 8.6.7 Chile Sales Analysis
  • 8.6.8 Rest of Latin America Sales Analysis
• 8.7. Middle East & Africa Sales Analysis
  • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.7.2 Middle East & Africa By Segment Sales Analysis
  • 8.7.3 Middle East & Africa By Country Sales Analysis
  • 8.7.4 Saudi Arabia Sales Analysis
  • 8.7.5 UAE Sales Analysis
  • 8.7.6 Israel Sales Analysis
  • 8.7.7 South Africa Sales Analysis
  • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEM COMPANIES

• 9.1. Ambulatory Polysomnography (PSG) System Market Competition
• 9.2. Partnership/Collaboration/Agreement
• 9.3. Merger And Acquisitions
• 9.4. New Product Launch
• 9.5. Other Developments

10. COMPANY PROFILES OF AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEM INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Market Concentration Rate
• 10.3. Compumedics Limited
  • 10.3.1 Company Overview
  • 10.3.2 Company Revenue
  • 10.3.3 Products
  • 10.3.4 Recent Developments
• 10.4. Nihon Kohden Corporation
  • 10.4.1 Company Overview
  • 10.4.2 Company Revenue
  • 10.4.3 Products
  • 10.4.4 Recent Developments
• 10.5. Koninklijke Philips N.V.
  • 10.5.1 Company Overview
  • 10.5.2 Company Revenue
  • 10.5.3 Products
  • 10.5.4 Recent Developments
• 10.6. SOMNOmedics GmbH
  • 10.6.1 Company Overview
  • 10.6.2 Company Revenue
  • 10.6.3 Products
  • 10.6.4 Recent Developments
• 10.7. Cadwell Industries Inc.
  • 10.7.1 Company Overview
  • 10.7.2 Company Revenue
  • 10.7.3 Products
  • 10.7.4 Recent Developments
• 10.8. Natus Medical Incorporated
  • 10.8.1 Company Overview
  • 10.8.2 Company Revenue
  • 10.8.3 Products
  • 10.8.4 Recent Developments
• 10.9. LöWenstein Medical Technology GmbH + Co. KG.
  • 10.9.1 Company Overview
  • 10.9.2 Company Revenue
  • 10.9.3 Products
  • 10.9.4 Recent Developments
• 10.10. Nox Medical
  • 10.10.1 Company Overview
  • 10.10.2 Company Revenue
  • 10.10.3 Products
  • 10.10.4 Recent Developments
• 10.11. Neurosoft
  • 10.11.1 Company Overview
  • 10.11.2 Company Revenue
  • 10.11.3 Products
  • 10.11.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies